Exploring DNA methylation, telomere length, mitochondrial DNA, and immune function in patients with Long-COVID

Andrea Polli, Lode Godderis, Dries S. Martens, et. al., , BMC Medicine volume 23, Article number: 60 (2025) Cite this article Abstract Background Long-COVID is defined as the persistency or development of new symptoms 3 months after the initial SARS-CoV-2…[...]

Read More

mRNA Vaccination and Arthritis: Etiological Mechanisms, Genomic Susceptibility, Diagnostic Pathways, and Therapeutic Outlook

John Murphy, President The COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have transformed infectious disease prevention, particularly during the COVID-19 pandemic. While their safety profile is robust, emerging evidence…[...]

Read More

COVID-19 and immune dysregulation: Genomic pathways, clinical manifestations, and therapeutic strategies

John Murphy, CEO & President, COVID-19 Long-haul Foundation Abstract SARS-CoV-2 provokes a uniquely heterogeneous and dynamic immune response that ranges from efficient viral control to fulminant hyperinflammation and prolonged immune…[...]

Read More

Long Covid: Hormone Imbalances and/or Rather Complex Immune Dysregulations? 

Christian A Koch, Journal of the Endocrine Society, Volume 8, Issue 5, May 2024, bvae043, https://doi.org/10.1210/jendso/bvae043  Commentary Approximately 5% of all individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…[...]

Read More